GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
B

Bliss GVS Pharma BLISSGVS.NS · INR

Health Care · NSE · 🇮🇳 India

Compare

654.75

+6.59%

Close of 9 Nov 2026, in INR

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in INR, from our data supplier.

FY2025

Revenue

₹8.10bn

FY2016FY2025

Net income

₹843.0m

FY2016FY2025

Free cash flow

₹296.3m

FY2016FY2025

Shareholders' equity

₹10.50bn

FY2016FY2025

Income statement

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue₹8.10bn₹7.70bn₹7.52bn₹7.47bn₹5.77bn₹6.89bn₹8.98bn₹3.73bn₹4.07bn₹5.47bn
Research and development—————₹76.9m₹142.6m₹25.1m——
Operating income₹972.7m₹950.5m₹986.5m₹274.2m₹894.5m₹972.6m₹1.51bn₹529.3m₹938.6m₹1.45bn
Net income₹843.0m₹754.5m₹708.6m₹150.4m₹684.9m₹972.6m₹1.24bn₹587.9m₹820.5m₹824.8m
Diluted earnings per share7.757.206.671.426.609.2511.985.697.978.00

Balance sheet

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Total assets₹13.01bn₹12.14bn₹11.57bn₹11.09bn₹10.77bn₹10.29bn₹9.05bn₹8.60bn₹10.23bn₹7.62bn
Cash and short-term investments₹1.50bn₹1.51bn₹725.7m₹1.46bn₹777.8m₹500.9m₹1.05bn₹1.52bn₹991.3m₹369.9m
Total liabilities₹2.50bn₹2.47bn₹2.73bn₹2.90bn₹2.69bn₹2.93bn₹2.59bn₹3.24bn₹5.36bn₹3.49bn
Debt₹554.6m₹769.9m₹894.2m₹1.08bn₹994.7m₹1.07bn₹968.3m₹1.12bn₹2.13bn₹1.00bn
Shareholders' equity₹10.50bn₹9.67bn₹8.84bn₹8.19bn₹8.08bn₹7.36bn₹6.46bn₹5.36bn₹4.87bn₹4.13bn
Shares outstanding109m105m106m106m104m105m103m103m103m103m

Cash flow

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operations₹1.06bn₹1.52bn₹343.1m₹1.35bn₹639.7m₹453.3m₹399.5m₹176.4m₹2.89bn₹1.13bn
Capital spending−₹762.9m−₹283.3m−₹938.0m−₹740.0m−₹91.2m−₹603.1m−₹437.7m−₹282.2m−₹1.04bn−₹133.1m
Free cash flow₹296.3m₹1.24bn−₹594.9m₹614.8m₹548.5m−₹149.8m−₹38.2m−₹105.8m₹1.86bn₹996.4m
Dividends paid−₹54.5m−₹53.9m−₹54.4m−₹53.3m−₹55.5m−₹125.0m−₹82.4m−₹74.5m−₹62.7m−₹61.6m

Latest quarters

By quarter end

Dec 2025Sept 2025Jun 2025Mar 2025Dec 2024Sept 2024Jun 2024Mar 2024
Revenue₹2.18bn₹2.44bn₹2.07bn₹1.98bn₹2.10bn₹2.18bn₹1.84bn₹1.98bn
Operating income₹239.3m₹235.0m₹331.3m₹130.5m₹222.4m₹345.0m₹274.8m₹215.0m
Net income₹232.7m₹272.5m₹430.4m₹155.4m₹238.0m₹242.6m₹207.0m−₹91.5m
Diluted earnings per share2.142.513.961.432.272.311.93-0.88
Cash from operations—₹775.0m—₹1.06bn—₹475.0m—₹1.52bn
Capital spending—−₹292.0m—−₹762.0m—−₹341.0m—−₹283.0m
Free cash flow—₹483.0m—₹297.0m—₹134.0m—₹1.24bn
Total assets—₹14.00bn—₹13.01bn—₹12.83bn—₹12.14bn
Cash and short-term investments—₹2.46bn—₹1.50bn—₹2.33bn—₹1.51bn
Debt—₹248.4m—₹325.6m—₹364.9m—₹448.7m
Shareholders' equity—₹11.32bn—₹10.50bn—₹10.10bn—₹9.67bn

Financial ratios

Data as of 24 Sept 2026

FY2026FY2025FY2024FY2023FY2022FY2021
Operating margin21.7%35.1%16.1%15.6%12.9%14.6%
Net margin13.9%10.4%9.9%9.5%2.0%12.0%
Return on equity10.8%8.0%7.8%8.0%1.8%8.5%
Return on assets8.7%6.5%6.2%6.1%1.4%6.4%
Free cash flow yield2.6%2.4%2.5%1.8%2.9%1.0%
Revenue growth14.5%5.7%2.5%1.3%29.8%-16.6%
Earnings growth53.2%11.7%6.5%371.1%-78.0%-29.6%
Current ratio4.02x4.81x5.08x3.61x3.33x3.76x
Debt to equity0.01x0.07x0.09x0.11x0.13x0.15x
Equity ratio79.9%80.7%79.7%76.4%73.8%75.1%
Interest coverage16.79x34.97x17.81x11.23x20.04x15.06x
R&D as a share of sales5.9%2.1%2.0%1.7%1.8%1.8%
Buybacks as a share of market value0.9%-3.7%1.3%-0.3%-2.0%1.3%

Growth per year

Compound annual rate

3 years5 years10 years
Revenue2.7%3.3%7.1%
Operating income52.5%0.0%0.5%
Net income77.6%-2.8%3.5%

Average margins

Over each period

1 year3 years5 years10 years
Operating margin12.2%10.3%11.6%14.9%
Net margin10.1%8.0%9.5%11.7%

Valuation history

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Price to earnings21.122.918.751.015.721.912.629.026.619.5
Price to sales2.22.21.81.01.93.11.74.65.42.9

Dividends and splits

Per share, in the currency the company pays

Paid for 16 years. Last went ex-dividend on 18 Feb 2026.

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019
Paid in the year1.000.500.500.500.500.501.001.00

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.